Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
Clinical trial NCT04114825 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04114825
- Sponsor
- RhoVac APS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-19
- Primary completion
- 2022-04-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.